Olaparib and adavosertib work best when given sequentially for DNA-damage response mutations in advanced tumors

Patients with cancers that are driven by certain mutations occurring in response to DNA damage can be safely treated with two drugs, olaparib and adavosertib, if they are given in sequence rather than concurrently. Presenting results from the phase Ib STAR clinical trial to the 34th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics in […]

Continue Reading

‘Britain’s dullest man’ creates calendar for 2023 celebrating the nation’s car parks

‘Britain’s dullest man’ has created his own brand new calendar for 2023, celebrating the nation’s car parks. Kevin Beresford branded himself the dullest man Britain has to offer. The 70-year-old spent months travelling the length and width of the country reviewing the car parks on offer from Land’s End to John o’ Groats. The president […]

Continue Reading